182 research outputs found
Killer Timing:The Temporal Uterine Natural Killer Cell Differentiation Pathway and Implications for Female Reproductive Health
Natural killer (NK) cells are the predominant maternal uterine immune cell component, and they densely populate uterine mucosa to promote key changes in the post-ovulatory endometrium and in early pregnancy. It is broadly accepted that (a) immature, inactive endometrial NK (eNK) cells in the pre-ovulatory endometrium become activated and transition into decidual NK (dNK) cells in the secretory stage, peri-implantation endometrium, and continue to mature into early pregnancy; and (b) that secretory-stage and early pregnancy dNK cells promote uterine vascular growth and mediate trophoblast invasion, but do not exert their killing function. However, this may be an overly simplistic view. Evidence of specific dNK functional killer roles, as well as opposing effects of dNK cells on the uterine vasculature before and after conception, indicates the presence of a transitory secretory-stage dNK cell (s-dNK) phenotype with a unique angiodevelopmental profile during the peri-implantation period, that is that is functionally distinct from the angiomodulatory dNK cells that promote vessel destabilisation and vascular cell apoptosis to facilitate uterine vascular changes in early pregnancy. It is possible that abnormal activation and differentiation into the proposed transitory s-dNK phenotype may have implications in uterine pathologies ranging from infertility to cancer, as well as downstream effects on dNK cell differentiation in early pregnancy. Further, dysregulated transition into the angiomodulatory dNK phenotype in early pregnancy will likely have potential repercussions for adverse pregnancy outcomes, since impaired dNK function is associated with several obstetric complications. A comprehensive understanding of the uterine NK cell temporal differentiation pathway may therefore have important translational potential due to likely NK phenotypic functional implications in a range of reproductive, obstetric, and gynaecological pathologies
Role of female sex hormones, estradiol and progesterone, in mast cell behavior
Female sex hormones have long been suspected to have an effect on mast cell (MC) behavior. This assumption is based on the expression of hormone receptors in MCs as well as on the fact that many MC-related pathophysiological alterations have a different prevalence in females than in males. Further, serum IgE levels are much higher in allergic female mice compared to male mice. Ovariectomized rats developed less airway inflammation compared to sham controls. Following estrogen replacement ovariectomized rats re-established airway inflammation levels’ found in intact females. In humans, a much higher asthma prevalence was found in women at reproductive age as compared to men. Serum levels of estradiol and progesterone have been directly correlated with the clinical and functional features of asthma. Around 30–40% of women who have asthma experienced worsening of their symptoms during the perimenstrual phase, the so-called perimenstrual asthma. Postmenopausal women receiving hormone replacement therapy have an increased risk of new onset of asthma. Beside, estrus cycle dependent changes on female sex hormones are related to changes on MC number in mouse uterine tissue and estradiol and progesterone were shown to induce uterine MC maturation and degranulation. We will discuss here the currently available information concerning the role of these female sex hormones on MC behavior
A comprehensive battery of flow cytometric immunoassays for the in vitro testing of chemical effects in human blood cells
BackgroundThere is a growing need for immunological assays to test toxic and modulatory effects of chemicals. The assays should be easy to use, reproducible and superior to cell line-based assays. We have therefore developed a comprehensive portfolio of assays based on primary human blood cells that are suitable for testing chemical effects.MethodsThe flow cytometry-based assays were designed to target a wide range of human peripheral blood mononuclear cells and whole blood, including T cells, NK cells, B cells, basophils and innate-like T cells such as γδT, MAIT and NKT cells. We have selected a set of activation markers for each immune cell, e.g: CD154 (T cells), CD137, CD107a (NK cells), CD63 (basophils), CD69, CD83 (B cells), CD69, IFN-γ (MAIT cells) and we selected cell specific stimuli: aCD3 antibodies (T cells); E. coli and cytokines IL-12/15/18 (MAIT cells); CpG ODN2006, R848 or aCD40 antibodies (B cells), fMLP or aFcϵR1 (basophils) or K562 cells (NK cells).ResultsBy selecting immune cell-specific markers and cell-specific stimuli, we were able to induce particular immune responses from the targeted immune cells. For example, the response to stimulation with anti-CD3 antibodies was in 36.8% of CD107a+CD8+ cells. Cytokine stimulation induced the production of IFN-γ in 30% of MAIT cells. After stimulation with E. coli, around 50% of MAIT cells produced TNF. About 40% of basophils responded to aFcƐR1 stimulation. Similar activation ranges were achieved in K562-stimulated NK cells.ConclusionOur test portfolio covers the most relevant immune cells present in human blood, providing a solid basis for in vitro toxicity and immunomodulatory testing of chemicals. By using human blood, the natural composition of cells found in the blood can be determined and the effects of chemicals can be detected at the cellular level
Safeguarding of Fetal Growth by Mast Cells and Natural Killer Cells
Uterine natural killer cells (uNKs) and mast cells (uMCs) are of crucial
importance for spiral artery (SA) remodeling and placentation. Mice deficient
for both NKs and MCs including uNKs and uMCs show markedly impaired SA
remodeling and their fetuses are growth-retarded. In contrast, the absence of
either NKs or MCs results in only minor impairment. This suggests that uNKs
can compensate for the effects of uMCs on SA remodeling and vice versa. To
test this hypothesis, we assessed uNK numbers in uMC-deficient mice as well as
uMC numbers in uNK-depleted mice. Notably, uMC-deficient C57BL/6J-KitW-sh/W-sh
(W-sh) mice showed markedly increased numbers of uNKs in contrast to wild
type, and the transfer of bone marrow-derived MCs reverted this phenotype.
Vice versa, uNK-deficient C57BL/6NTac-IL15tm1ImxN5 (IL-15−/−) mice had
significantly increased numbers of uMCs and MC-specific proteases. Our results
suggest that uNKs and uMCs can counterbalance their effects at the
feto–maternal interface and jointly promote SA remodeling and placentation
Human Breast Milk: From Food to Active Immune Response With Disease Protection in Infants and Mothers
Breastfeeding is associated with long-term wellbeing including low risks of infectious
diseases and non-communicable diseases such as asthma, cancer, autoimmune
diseases and obesity during childhood. In recent years, important advances have been
made in understanding the human breast milk (HBM) composition. Breast milk
components such as, non-immune and immune cells and bioactive molecules, namely,
cytokines/chemokines, lipids, hormones, and enzymes reportedly play many roles in
breastfed newborns and in mothers, by diseases protection and shaping the immune
system of the newborn. Bioactive components in HBM are also involved in tolerance and
appropriate inflammatory response of breastfed infants if necessary. This review
summarizes the current literature on the relationship between mother and her infant
through breast milk with regard to disease protection. We will shed some light on the
mechanisms underlying the roles of breast milk components in the maintenance of health
of both child and mother
Insights into Early-Pregnancy Mechanisms: Mast Cells and Chymase CMA1 Shape the Phenotype and Modulate the Functionality of Human Trophoblast Cells, Vascular Smooth-Muscle Cells and Endothelial Cells
Spiral-artery (SA) remodeling is a fundamental process during pregnancy that involves the
action of cells of the initial vessel, such as vascular smooth-muscle cells (VSMCs) and endothelial
cells, but also maternal immune cells and fetal extravillous trophoblast cells (EVTs). Mast cells
(MCs), and specifically chymase-expressing cells, have been identified as key to a sufficient SA remodeling process in vivo. However, the mechanisms are still unclear. The purpose of this study
is to evaluate the effects of the MC line HMC-1 and recombinant human chymase (rhuCMA1)
on human primary uterine vascular smooth-muscle cells (HUtSMCs), a human trophoblast cell
line (HTR8/SV-neo), and human umbilical-vein endothelial cells (HUVEC) in vitro. Both HMC-1
and rhuCMA1 stimulated migration, proliferation, and changed protein expression in HUtSMCs.
HMC-1 increased proliferation, migration, and changed gene expression of HTR8/SVneo cells, while
rhuCMA treatment led to increased migration and decreased expression of tissue inhibitors of matrix
metalloproteinases. Additionally, rhuCMA1 enhanced endothelial-cell-tube formation. Collectively,
we identified possible mechanisms by which MCs/rhuCMA1 promote SA remodeling. Our findings
are relevant to the understanding of this crucial step in pregnancy and thus of the dysregulated
pathways that can lead to pregnancy complications such as fetal growth restriction and preeclampsia
Transfer of regulatory T cells into abortion-prone mice promotes the expansion of uterine mast cells and normalizes early pregnancy angiogenesis
Implantation of the fertilized egg depends on the coordinated interplay of
cells and molecules that prepare the uterus for this important event. In
particular, regulatory T cells (Tregs) are key regulators as their ablation
hinders implantation by rendering the uterus hostile for the embryo. In
addition, the adoptive transfer of Tregs can avoid early abortion in mouse
models. However, it is still not defined which mechanisms underlie Treg
function during this early period. Cells of the innate immune system have been
reported to support implantation, in part by promoting angiogenesis. In
particular, uterine mast cells (uMCs) emerge as novel players at the fetal-
maternal interface. Here, we studied whether the positive action of Tregs is
based on the expansion of uMCs and the promotion of angiogenesis. We observed
that abortion-prone mice have insufficient numbers of uMCs that could be
corrected by the adoptive transfer of Tregs. This in turn positively
influenced the remodeling of spiral arteries and placenta development as well
as the levels of soluble fms-like tyrosine kinase 1 (sFlt-1). Our data suggest
an interplay between Tregs and uMCs that is relevant for the changes required
at the feto-maternal interface for the normal development of pregnancy
Estradiol and progesterone regulate the migration of mast cells from the periphery to the uterus and induce their maturation and degranulation
Background: Mast cells (MCs) have long been suspected as important players for implantation based on the fact that their degranulation causes the release of pivotal factors, e.g., histamine, MMPs, tryptase and VEGF, which are known to be involved in the attachment and posterior invasion of the embryo into the uterus. Moreover, MC degranulation correlates with angiogenesis during pregnancy. The number of MCs in the uterus has been shown to fluctuate during menstrual cycle in human and estrus cycle in rat and mouse indicating a hormonal influence on their recruitment from the periphery to the uterus. However, the mechanisms behind MC migration to the uterus are still unknown. Methodology/Principal Findings: We first utilized migration assays to show that MCs are able to migrate to the uterus and to the fetal-maternal interface upon up-regulation of the expression of chemokine receptors by hormonal changes. By using a model of ovariectomized animals, we provide clear evidences that also in vivo, estradiol and progesterone attract MC to the uterus and further provoke their maturation and degranulation. Conclusion/Significance: We propose that estradiol and progesterone modulate the migration of MCs from the periphery to the uterus and their degranulation, which may prepare the uterus for implantation.Facultad de Ciencias Veterinaria
Control of Uterine Microenvironment by Foxp3+ Cells Facilitates Embryo Implantation
Implantation of the fertilized egg into the maternal uterus depends on the fine balance between inflammatory and anti-inflammatory processes. Whilst regulatory T cells (Tregs) are reportedly involved in protection of allogeneic fetuses against rejection by the maternal immune system, their role for pregnancy to establish, e.g., blastocyst implantation, is not clear. By using 2-photon imaging we show that Foxp3(+) cells accumulated in the mouse uterus during the receptive phase of the estrus cycle. Seminal fluid further fostered Treg expansion. Depletion of Tregs in two Foxp3.DTR-based models prior to pairing drastically impaired implantation and resulted in infiltration of activated T effector cells as well as in uterine inflammation and fibrosis in both allogeneic and syngeneic mating combinations. Genetic deletion of the homing receptor CCR7 interfered with accumulation of Tregs in the uterus and implantation indicating that homing of Tregs to the uterus was mediated by CCR7. Our results demonstrate that Tregs play a critical role in embryo implantation by preventing the development of a hostile uterine microenvironment.DFG grants: (ZE526/4-2, SFB854TP7), Wilhelm Sander Stiftung Germany grant: (2009.022.1), Helmholtz Alliance for Immunotherapy, FCT, Medical Faculty Otto-von-Guericke University PhD grant
Chymase-Cre; Mcl-1fl/fl Mice Exhibit Reduced Numbers of Mucosal Mast Cells
Mast cells (MCs) are considered as key effector cells in the elicitation of allergic symptoms, and they are essential players in innate and adaptive immune responses. In mice, two main types of MCs have been described: connective tissue MCs (CTMCs) and mucosal MCs (MMCs). However, little is known about the biological functions of MMCs, which is due to the lack of suitable models to investigate MMCs in vivo. Here, we aimed to generate a mouse model selectively deficient in MMCs. It has been previously described that Cre expressed under the control of the baboon α-chymase promotor is predominantly localized in MMCs. Therefore, we mated α-chymase-Cre transgenic mice with mice bearing a floxed allele of the myeloid cell leukemia sequence 1 (Mcl-1). Mcl-1 encodes for an intracellular antiapoptotic factor in MCs; hence, a selective reduction in MMCs was expected. Our results show that this new mouse model contains markedly reduced numbers of MMCs in mucosal tissues, whereas numbers of CTMCs are normal. Thus, Chm-Cre; Mcl-1fl/fl mice are a useful tool for the investigation of the pathophysiological functions of MMCs in vivo
- …